<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00736307</url>
  </required_header>
  <id_info>
    <org_study_id>ROYAN-EYE-001</org_study_id>
    <nct_id>NCT00736307</nct_id>
  </id_info>
  <brief_title>Autologous Transplantation of Cultivated Limbal Stem Cells on Amniotic Membrane in Limbal Stem Cell Deficiency (LSD) Patients</brief_title>
  <official_title>Transplantation of Ex-Vivo Expanded Human Limbal Epithelial Stem Cells (LSC) on Amniotic Membrane (AM) for Limbal Stem Cell Deficiency (LSCD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royan Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Small Business Developing Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Labafi Nejad Eye Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Royan Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy, safety, and long term outcomes of ex
      vivo cultured limbal stem cell on amniotic membrane transplantation for corneal surface
      reconstruction in cases of partial and sever limbal stem cell deficiency.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ocular surface is composed of corneal and conjunctival epithelial cells. Normal cornea is
      essential for normal vision. Defects in renewal and repair of ocular surface as a result of
      limbal stem cell deficiency are now known to cause varying ocular surface morbidity including
      persistent photophobia, repeated and persistent surface breakdown and overt
      conjunctivalisation of the cornea. Restoring ocular health in these eyes has traditionally
      been frustrating. Ex vivo cultured limbal epithelial stem cells have been used successfully
      to treat limbal stem cell deficiency. Ex-vivo limbal stem cell allograft transplantation is
      achieved by harvesting limbal corneal tissue from donor eyes (either matched living relatives
      or cadaveric donors). The donor stem cells are obtained by excising a small area of the
      conjunctiva at the limbus and are a minor procedure. The tissue so obtained is then grown in
      tissue culture and once the cells have multiplied sufficiently, small sheets are transplanted
      on to the affected eye(s), backed with an amniotic membrane. The surgery is undertaken under
      either local or general anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Snellen visual acuity</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>corneal epithelial integrity and stability</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impression cytology</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extent of retarding recurrent neovascularisation</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Limbal Stem Cell Deficiency</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cultured limbal stem cells Transplantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cultured limbal stem cells Transplantation</intervention_name>
    <description>Transplantation of cultivated limbal epithelium on amniotic membrane</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Transplantation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with unilateral limbal stem cell insufficiency and totally corneal
             vascularization

          -  Presence of Goblet cells on the cornea

          -  Minimum tear was about 5 mm

          -  Minimum duration of deficiency was 3 years

          -  Vision was Light Perception

        Exclusion Criteria:

          -  Systemic disease affecting both eyes such as Stevens-Johnson syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hamid Gorabi, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Royan institute, Tehran, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammadali Javadi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Labbafinejad Ophthalmic Research Center, Tehran, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hossein Baharvand, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royan institute, Tehran, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alireza Baradaran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Labbafinejad, Ophthalmic Research Center, Tehran, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marzieh Ebrahimi, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Royan Institute, Tehran, Iran</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royan Institute</name>
      <address>
        <city>Tehran</city>
        <zip>1665659911</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Labbafinejad Ophthalmic Research Center</name>
      <address>
        <city>Tehran</city>
        <zip>16666</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <link>
    <url>http://www.royaninstitute.org</url>
  </link>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2008</study_first_submitted>
  <study_first_submitted_qc>August 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2008</study_first_posted>
  <last_update_submitted>July 14, 2011</last_update_submitted>
  <last_update_submitted_qc>July 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2011</last_update_posted>
  <responsible_party>
    <name_title>Hamid Gourabi/ Chief</name_title>
    <organization>Royan Institute</organization>
  </responsible_party>
  <keyword>limbal stem cell deficiency</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

